Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
**The FDA does not review or approve any compounded medications for safety or effectiveness
Roivant dermatology subsidiary to be acquired by Organon Organon has agreed to buy Roivants dermatology subsidiary Dermavant for $175 million upfront plus more than $1 billion in potential additional payments if certain milestones are hit
No significant differences were seen in the microvascular complications among the 3 study groups
Prior authorizations, high cash prices, and a system that keeps pushing obesity patients aside
In this study, our genetic screening of the previously constructed hairpin RNA-based Arabidopsis library 19 identified a glutathione (GSH)-deficient mutant that highly accumulated Glu, the previously defined molecule crucial for activation of plant defense, but disharmoniously exhibited attenuation of defense signaling events
US$ 20.24
US$ 26.63
US$ 27.20
US$ 23.85
US$ 26.74
